- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Immunomedics inks therapy joint venture
Immunomedics of Morris Plains, NJ, announced this month that it has entered into a joint venture with Beckman Coulter. The venture, IBC Pharmaceuticals, will take advantage of the two companies' compatible technologies to develop new cancer treatments.
Immunomedics of Morris Plains, NJ, announced this month that it has entered into a joint venture with Beckman Coulter. The venture, IBC Pharmaceuticals, will take advantage of the two companies' compatible technologies to develop new cancer treatments.
Immunomedics will supply its technological and marketing expertise to the venture, as well as one of its antibody patents. Fullerton, CA-based Beckman Coulter will contribute a bispecific antibody targeting technology developed by the company's Immunotech subsidiary in Marseilles, France. The technology, called the affinity enhancement system, works in a two-pronged method: A patient is first injected with the bispecific antibody that attaches to cancer cells, then is injected with a therapeutic. The process allows the tumor-killing drug to bind directly to cancer cells and kill them selectively, without affecting healthy tissue.
Immunomedics will continue its own R&D program independently of IBC, according to company chairman Dr. David Goldenberg. In addition to other diagnostic agents, Immunomedics has therapeutic agent CEA-Cide in phase I/II dose-ranging trials.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
